Clinical Trials in Miami

Showing 1961-1980 of 5,521 trials

Photobiomodulation to Demonstrate Safety and Reduce the Incidence of Oral Mucositis in Adult Head & Neck Cancer Patients

NCT03972527

The overall purpose of this clinical study is to evaluate safety and efficacy of the MuReva Phototherapy System with a light delivery mouthpiece to reduce the severity of oral mucositis (OM) in adult patients with squamous cell carcinoma of the oral cavity, oropharynx, tonsils and base of tongue receiving radiation therapy with or without concurrent chemotherapy.

Oral Mucositis (Ulcerative)Oral Mucositis (Ulcerative) Due to RadiationOral Mucositis (Ulcerative) Due to Antineoplastic Therapy+1 more

MuReva Phototherapy Inc.85 participantsStarted Aug 2022

Birmingham, Alabama, United States • Long Beach, California, United States • Miami, Florida, United States +9 more locations

COMPLETEDPhase 1< 1 mile

Open-Label Study to Evaluate the Safety, Tolerability, and PK of Aramchol in Subjects With Hepatic Impairment

NCT04480827

Phase 1, multicenter, open-label, 2-part, single- and multiple-dose study designed to assess the effect of hepatic insufficiency on the PK of aramchol

Hepatic Impairment

Galmed Research and Development, Ltd.57 participantsStarted Feb 2020

Miami, Florida, United States • Orlando, Florida, United States • Knoxville, Tennessee, United States

Photobiomodulation to Demonstrate Safety and Reduce the Incidence of Oral Mucositis in Adult Head & Neck Cancer Patients

Open-Label Study to Evaluate the Safety, Tolerability, and PK of Aramchol in Subjects With Hepatic Impairment

Find Trials by Condition in Miami

Optimal Protamine Dosing for Heparin Reversal Following Cardiopulmonary Bypass

A Study to Assess the Effects of RO6889450 (Ralmitaront) in Participants With Schizophrenia or Schizoaffective Disorder and Negative Symptoms

Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children

A Study of Atezolizumab (Anti-PD-L1 Antibody) in Combination With Enzalutamide in Participants With Metastatic Castration-Resistant Prostrate Cancer (mCRPC) After Failure of an Androgen Synthesis Inhibitor And Failure of, Ineligibility For, or Refusal of a Taxane Regimen

Elranatamab Expanded Access Protocol in Adults With Relapsed/Refractory Multiple Myeloma

A Study to Evaluate the Effectiveness and Safety of SKI-O-703 in Patients Experiencing Active Rheumatoid Arthritis Despite Treatment With Conventional Therapies.

Efficacy and Safety of Roxadustat for Treatment of Anemia in Participants With Lower Risk Myelodysplastic Syndrome With Low Red Blood Cell Transfusion Burden

The clonoSEQ® Watch Registry

Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)

Study of OMNI System in OAG (GEMINI)

A Study Investigating the Efficacy and Safety of Intravitreal Injections of ANX007 in Patients With Geographic Atrophy

ILUMIEN IV: OPTIMAL Percutaneous Coronary Intervention (PCI)

A Study Of PF-06463922 An ALK/ROS1 Inhibitor In Patients With Advanced Non Small Cell Lung Cancer With Specific Molecular Alterations

HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Safety, Tolerability, and Immunogenicity of Zika Vaccine mRNA-1893 in Healthy Flavivirus Seropositive and Seronegative Adults

Efficacy, Safety, and Tolerability of Gebasaxturev (V937) Administered Intravenously or Intratumorally With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone in Participants With Advanced/Metastatic Melanoma (V937-011)

A Study of Cemdisiran in Adults With Immunoglobulin A Nephropathy (IgAN)

Training for Health Professionals In Tanzania